Table 4.
Data regarding BE and normal epithelium with and without inflammation.
| Parameter | BE+ Infl BE− Infl |
Normal Infl. Normal No Infl. |
OR/t | p or CI | |
|---|---|---|---|---|---|
| Serum Cr− | 1.040 ± 0.185 1.409 ± 3.032 |
NSS NSS |
t-Test | <0.022 | |
| ACE exposure | 17/45 (78%) 160/95 |
(82%) | 0.51 | 0.27–0.98 | |
| Urinary Cr− | 115 ± 75 184 ± 100 |
t-Test | <0.022 | ||
| Quan EtOH | 13/20 (65%) 7/20 (35%) |
NSS | NSS | 6.86 | <0.0002 |
| Obese BMI > 28 | 7/23 (30%) 22/33 (67%) |
NSS | NSS | 0.22 | <0.014 |
| AA Ethnicity | 8/38 (21%) | NSS | 104/167(62%) | 0.16 | 0.07–0.37 |
| Dysplasia * | 8/26 (31%) 9/39 (23%) |
N/A | N/A | 0.6 | |
BE+—patients with BE; BE−—patients without BE; infl.—inflammation. OR—odds ratio; p—probability; CI—confidence interval; Cr−—creatinine; ACE—angiotensin converting enzyme inhibitors; t-test—Students t test; ETOH—ethanol intake; BMI—body mass index; AA—African American; NSS—not statistically significant; N/A—not applicable. *—none had high-grade dysplasia, but 5 patients had findings of indefinite dysplasia only in stable BE but with a significant difference at p < 0.046. BE was seen in 46 patients overall.